Qing Song Health Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,122	982.56	868.66	636.69	357.54
Revenue Growth (YoY)	14.16%	13.11%	36.44%	78.08%	48.83%
Cost of Revenue	974.07	858.74	753.65	571.12	330.73
Gross Profit	147.62	123.82	115.02	65.57	26.81
Selling, General & Admin	89.62	79.7	61.11	51.66	31.54
Other Operating Expenses	-0.21	0.01	0.08	-0.41	-0.72
Operating Expenses	90.59	79.75	61.5	51.25	30.79
Operating Income	57.03	44.07	53.52	14.32	-3.98
Interest Expense	-25.38	-23.1	-17.64	-14	-11.3
Interest & Investment Income	8	4.5	3.16	0.8	0.59
Earnings From Equity Investments	-	-	-	-	-0.16
Other Non Operating Income (Expenses)	72.31	26.28	37.37	26.5	12.99
EBT Excluding Unusual Items	111.96	51.75	76.42	27.61	-1.87
Gain (Loss) on Sale of Investments	-	-0.48	3.69	-1.05	0.04
Gain (Loss) on Sale of Assets	-	-0.61	-0.97	-0.29	0.01
Other Unusual Items	-	-	-	1.22	1.46
Pretax Income	111.96	50.66	79.14	27.5	-0.36
Income Tax Expense	18.28	9.96	20.31	8.98	-0.58
Earnings From Continuing Operations	93.67	40.7	58.83	18.52	0.22
Minority Interest in Earnings	-1.97	-0.15	0.57	4.81	-2.18
Net Income	91.7	40.55	59.4	23.33	-1.97
Net Income to Common	91.7	40.55	59.4	23.33	-1.97
Net Income Growth	126.14%	-31.73%	154.61%	-	-
Shares Outstanding (Basic)	66	60	60	60	60
Shares Outstanding (Diluted)	66	60	60	60	60
Shares Change (YoY)	9.85%	-0.01%	0.01%	0.01%	15.91%
EPS (Basic)	1.39	0.68	0.99	0.39	-0.03
EPS (Diluted)	1.39	0.68	0.99	0.39	-0.04
EPS Growth	105.84%	-31.73%	156.24%	-	-
Free Cash Flow	-152.12	123.14	-22.26	34.85	13.83
Free Cash Flow Per Share	-2.31	2.05	-0.37	0.58	0.23
Dividend Per Share	-	0.480	0.083	-	-
Dividend Growth	-	480.41%	-	-	-
Gross Margin	13.16%	12.60%	13.24%	10.30%	7.50%
Operating Margin	5.08%	4.49%	6.16%	2.25%	-1.11%
Profit Margin	8.18%	4.13%	6.84%	3.66%	-0.55%
Free Cash Flow Margin	-13.56%	12.53%	-2.56%	5.47%	3.87%
EBITDA	199.25	108.66	109.43	67.77	38.37
EBITDA Margin	17.76%	11.06%	12.60%	10.64%	10.73%
D&A For EBITDA	142.22	64.59	55.91	53.45	42.35
EBIT	57.03	44.07	53.52	14.32	-3.98
EBIT Margin	5.08%	4.49%	6.16%	2.25%	-1.11%
Effective Tax Rate	16.33%	19.66%	25.66%	32.65%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.